Health
NIH to conduct large trial for COVID-19 polyclonal antibody therapies – News-Medical.Net
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted…
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at sites around the world, for a test trial called ACTIV-2, which is a part of NIH’s Accelerating COVID-19 Therapeutic Interventions…
-
Business18 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News15 hours agoTips to improve engagement – Proctor
-
General24 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz